Matinas BioPharma
MTNB
MTNB
31 hedge funds and large institutions have $6.6M invested in Matinas BioPharma in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$248K | |
| 2 | +$150K | |
| 3 | +$94.9K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$39K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$23K |
Top Sellers
| 1 | -$319K | |
| 2 | -$186K | |
| 3 | -$157K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$138K |
| 5 |
Millennium Management
New York
|
-$137K |